International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Spironolactone 5 mg/mL in SuspendIt Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s): 496

Spironolactone 5 mg/mL in SuspendIt Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Spironolactone 5 mg/mL in SuspendIt Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, spironolactone, potassium-sparing diuretic, aldosterone antagonist, high blood pressure, hypertension, antihypertensive agent, congestive heart failure, fluid overload, fluid retention, edema, ascites, liver failure, hepatic disease

Related Categories: FORMULATIONS, GASTROENTEROLOGY, CARDIOLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A	May/Jun 2020 Pg. 238-241
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Metolazone 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2010 Pg. 157
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2023 Pg. 326
Bumetanide 0.25-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 61
Chlorothiazide 50-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2014 Pg. 326
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 232
Return to Top